Connor, Clark & Lunn Investment Management (CC&L)’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.6M Sell
27,937
-30,358
-52% -$14.5M 0.03% 390
2025
Q4
$33.9M Sell
58,295
-27,478
-32% -$14M 0.09% 188
2025
Q3
$39.3M Sell
85,773
-14,322
-14% -$5.34M 0.12% 157
2025
Q2
$30.3M Sell
100,095
-2,265
-2% -$675K 0.11% 171
2025
Q1
$33.9M Sell
102,360
-928
-0.9% -$305K 0.15% 120
2024
Q4
$31.9M Buy
103,288
+31,205
+43% +$8.78M 0.14% 116
2024
Q3
$15.3M Sell
72,083
-10,979
-13% -$2.81M 0.07% 203
2024
Q2
$23.3M Sell
83,062
-10,535
-11% -$2.51M 0.1% 168
2024
Q1
$25M Buy
93,597
+39,490
+73% +$9.3M 0.11% 170
2023
Q4
$12.5M Buy
54,107
+2,421
+5% +$424K 0.06% 246
2023
Q3
$7.55M Sell
51,686
-14,075
-21% -$2.65M 0.04% 297
2023
Q2
$15.2M Sell
65,761
-2,903
-4% -$786K 0.08% 196
2023
Q1
$16.6M Buy
68,664
+8,257
+14% +$2.25M 0.09% 178
2022
Q4
$17.5M Buy
60,407
+35,418
+142% +$3.46M 0.1% 158
2022
Q3
$1.62M Buy
24,989
+18,264
+272% +$1.27M 0.01% 538
2022
Q2
$481K Buy
6,725
+3,376
+101% +$248K ﹤0.01% 791
2022
Q1
$329K Sell
3,349
-1,096
-25% -$92.4K ﹤0.01% 856
2021
Q4
$377K Buy
4,445
+1,871
+73% +$154K ﹤0.01% 858
2021
Q3
$205K Buy
+2,574
New +$222K ﹤0.01% 944
2019
Q1
Sell
-6,650
Closed -$750K 996
2018
Q4
$750K Sell
6,650
-1,800
-21% -$279K 0.01% 613
2018
Q3
$1.81M Buy
+8,450
New +$2.12M 0.01% 456
2016
Q3
Sell
-10,749
Closed -$98K 887
2016
Q2
$98K Hold
10,749
﹤0.01% 804
2016
Q1
$90K Hold
10,749
﹤0.01% 772
2015
Q4
$132K Buy
10,749
+4,018
+60% +$110K ﹤0.01% 734
2015
Q3
$410K Buy
6,731
+3,725
+124% +$269K ﹤0.01% 555
2015
Q2
$235K Sell
3,006
-425
-12% -$35.7K ﹤0.01% 532
2015
Q1
$233K Hold
3,431
﹤0.01% 484
2014
Q4
$318K Buy
3,431
+885
+35% +$91.5K ﹤0.01% 453
2014
Q3
$268K Buy
+2,546
New +$354K ﹤0.01% 463

Other funds holding MDGL